Recall of Clonazepam Anxiety Drug After Potential Life-Threatening Labeling Error
A voluntary recall in the United States has been issued for clonazepam (the generic name for Klonopin), an anxiety-reducing drug, due to a potentially fatal labeling mistake. The recall involves 16 lots of clonazepam Orally Disintegrating Tablets, which were found to be mislabeled with incorrect strengths and National Drug Code (NDC) numbers. The Pennsylvania-based pharmaceutical […]
Cancer Causing Compounds Found in Pfizer Blood Pressure Drugs and Company Issues Recall
Pfizer, Inc. announced on Mar. 21, 2022 that it was recalling three drugs used to treat high blood pressure due to an excessive amount of nitrosamines found in the tablets. The compounds can increase the risk of cancer if people are exposed to them at high levels over a period of time.1 Pfizer Issues Press […]
